⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 1 hour ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU December 18, 2023

ADHD medicines

📷 Wikipedia: Atomoxetine · Source
ADHD medicines
📷 Wikipedia: Atomoxetine · Source
INN
atomoxetine;methylphenidate;lisdexamfetamine
Forms
Various presentations in various strengths
Area
Attention Deficit Disorder with Hyperactivity
Alternatives
Yes
⚠️
Shortage ongoing
atomoxetine;methylphenidate;lisdexamfetamine is currently in short supply in EU.
📈 Timeline
12 days active so far
May 16, 2026 May 27, 2026

What is this? These are medicines used to help people with ADHD. They come in different forms and strengths.

What's happening? Some ADHD medicines are in short supply right now. This means they may be hard to find in some places.

Does this affect me? If you or someone in your family takes ADHD medicine, you might be affected.

What should I do? Talk to your pharmacist or doctor before making any changes to your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Brand(s) / product name(s)
ADHD medicines
Agency-published detail

INN: atomoxetine;methylphenidate;lisdexamfetamine · Forms: Various presentations in various strengths · Area: Attention Deficit Disorder with Hyperactivity · Alternatives: Yes

First published
December 18, 2023
Last refreshed by us
19 hours ago
Severity (as classified)
High
Official source
https://www.ema.europa.eu/en/medicines/human/shortages/adhd-medicines

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
ADHD medicines. INN: atomoxetine;methylphenidate;lisdexamfetamine · Forms: Various presentations in various strengths · Area: Attention Deficit Disorder with Hyperactivity · Alternatives: Yes
▸ When was this alert issued?
This alert was issued on December 18, 2023 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.